On March 25, 2013, the Board of Directors of Anthera Pharmaceuticals, Inc., on the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Sanford Zweifach to serve on the Board as a Class I director. Sanford Zweifach is a senior executive with over 20 years in the life sciences industry. partnering, business development, operational and financial experience, private and public investing and capital raising. From 2005 until 2010, Mr. Zweifach was a Managing Director at Reedland Capital Partners.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -98.51% |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from S&P TMI Index | CI |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
-98.51% | 26 | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ANTH Stock
- News Anthera Pharmaceuticals, Inc.
- Anthera Pharmaceuticals, Inc. Appoints Sanford Zweifach as Class I Director